Home » Topics » Regulatory » Patents

Patents
RSS

Pfizer describes new IL-2 production inhibitors

July 18, 2022

Janssen Pharmaceutica presents new Mcl-1 inhibitors

July 18, 2022

Novartis divulges new cGAS inhibitors

July 18, 2022

Sunshine Lake Pharma patents new chymotrypsin inhibitors

July 18, 2022

BioWorld MedTech Patent Highlights: Week 27

From Current Patent Gazette

July 15, 2022

BioWorld MedTech presents Patent Highlights, an excerpt of the most important med-tech patents from this week's Cortellis Patents Gazette.

Amgen describes new PRMT5 inhibitors

July 15, 2022

Zydus Lifesciences identifies new PCSK9 inhibitors

July 15, 2022

GlaxoSmithKline synthesizes new Nav1.8 channel blockers

July 15, 2022

Pandeia Therapeutics patents new GPR88 agonists

July 15, 2022

Chiesi Farmaceutici discloses new ROCK inhibitors

July 15, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...